1,664 filings
Page 50 of 84
8-K
q9vnq
19 Oct 09
Other Events
12:00am
8-K
bjcw0soocs1
5 Oct 09
Other Events
12:00am
8-K
vdqo11rg
29 Sep 09
Other Events
12:00am
8-K
h49u92f
24 Sep 09
Other Events
12:00am
8-K
rbgbdm8en54 u0
18 Sep 09
Other Events
12:00am
8-K
dqufll17dhzxi2iz8
8 Sep 09
Update on velaglucerase alfa
12:00am
8-K
moywozgkwul8 awwnj0
4 Sep 09
Other Events
12:00am
8-K
pi9aqt2cgtbu024j
3 Sep 09
Other Events
12:00am
UPLOAD
gc8k2h1 xco7oy1deks
2 Sep 09
Letter from SEC
12:00am
8-K
x1277nz39ugktk1g0
1 Sep 09
Other Events
12:00am
8-K
0w6b8a
1 Sep 09
Shire Completes Submission of NDA for velaglucerase alfa for Type 1 Gaucher disease and Reports Positive Results for Remaining Two Phase III Trials
12:00am
8-K
zmx9obygroun6qp6
19 Aug 09
Other Events
12:00am
8-K
3xs1j fzng4fy3srm7i
7 Aug 09
Other Events
12:00am
8-K
q6hb4 pyha
5 Aug 09
Core portfolio of products delivers 20% sales growth
12:00am
8-K
qrgw3d9rf nobn
4 Aug 09
Other Events
12:00am
8-K
n692ol0 nugonp21n2
4 Aug 09
Treatment Protocol Accepted and Rolling Submission of New Drug Application Initiated
12:00am
CT ORDER
eq1x1
3 Aug 09
Confidential treatment order
12:00am
8-K
5da8jfrqhbjo5j26
28 Jul 09
FDA Issues Complete Response Letter for INTUNIV™ (guanfacine) Extended Release for the Treatment of ADHD in Children and Adolescents
12:00am